image
NLS Pharmaceutics AG NLSP
Healthcare - Biotechnology - NASDAQ - CH
Watchlist
$ 3.13
-6.29 %
$ 7.74 M
Market Cap
-0.46
P/E
BALANCE SHEET
1.85 M ASSETS
-80.09%
Growth Rates
1Year -80.09%
3Years 15.08%
5Years 66.20%
7Years 0.00%
10Years 0.00%
10.7 M LIABILITIES
78.13%
Growth Rates
1Year 78.13%
3Years 1.56%
5Years 3.58%
7Years 0.00%
10Years 0.00%
-8.83 M EQUITY
-269.25%
Growth Rates
1Year -269.25%
3Years 0.56%
5Years -0.05%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition NLS Pharmaceutics AG
image
Current Assets 1.82 M
Cash & Short-Term Investments 898 K
Receivables 0
Other Current Assets 925 K
Non-Current Assets 23.6 K
Long-Term Investments 0
PP&E 6.69 K
Other Non-Current Assets 16.9 K
Current Liabilities 7.92 M
Accounts Payable 4.63 M
Short-Term Debt 1.63 M
Other Current Liabilities 1.65 M
Non-Current Liabilities 2.76 M
Long-Term Debt 0
Other Non-Current Liabilities 2.76 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 0.9 8.9 5.4 93.7 K 0.2 6.68 K 2.2
Short Term Investments 0 0 0 0 0 0 0
Receivables 0 0 0 0 75.4 K 36.9 K 0
Inventory 0 41.2 K 38.6 K 61.2 K 0 9.36 K 0
Other Current Assets 0.9 0.2 0.2 14.4 K 15.1 K 46.6 K 2.63 K
Total Current Assets 1.8 9.2 5.7 0.2 0.4 90.2 K 2.3
PP&E 6.69 K 18.1 K 29.5 K 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 68 K 54.5 K 55.5 K 0
Other Long Term Assets 16.9 K 12.1 K 12 K 0.9 0.3 1 14.4 K
Other Assets 0 0 1 1 0 0 0
Total Assets 1.8 9.3 5.8 1.2 0.7 0.1 2.3
LIABILITIES
Accounts Payable 4.6 2.4 1.7 4.0 2.5 1.1 0.6
Short Term Debt 1.6 0 0 1.8 0.7 0.7 0
Other Current Liabilities 1.7 1.0 0.7 1.4 0.8 0.6 0.4
Total Current Liabilities 7.9 3.4 2.4 7.2 4.0 2.4 1.0
Long Term Debt 0 0 0 0.3 0.2 6.4 8.9
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0.3 0.1 0.3 0.2 0.2 0.2 0.1
Total Liabilities 10.7 6.0 5.2 10.2 6.9 9.0 10.0
EQUITY
Common Stock 0.7 0.7 0.3 0.1 0.1 0.1 0.1
Retained Earnings (70.4) (58.2) (41.7) (29.8) (26.9) (21.5) (16.3)
Other Accumulative Comprehensive Income/Loss (0.2) 50.8 K (0.2) 19.4 K 18.7 K 11.3 K 9.99 K
Total Equity (8.8) 3.3 0.5 (9.0) (6.2) (8.8) (7.7)
Total Liabilities and Equity 1.8 9.3 5.8 1.2 0.7 0.1 2.3
SHARES OUTSTANDING
Common Shares Outstanding 38.2 19.7 14.7 4.8 11.1 11.8 11.8